Clinical Trial Update: BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BuEAM conditioning before autologous stem cell transplantation for diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Melphalan (Melphalan)

Snippet

Sponsor: Inje University | Conditions: Non Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN